Stock listing
THAT Stock Price, News, Filings & Events — Thalia Therapeutics Plc
Selected listing: THAT · LSE · GBX · GB
THAT:LSE is the primary listing for Thalia Therapeutics Plc, a public company with a market capitalization of approximately £16.63 million. Thalia Therapeutics is dedicated to developing innovative therapeutic solutions. The company’s official page provides updates on its operations, recent news, regulatory filings, and upcoming events relevant to investors and stakeholders.

- Ticker
- THAT:LSE
- Asset type
- Stock
- Market cap
- $22.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- GBX
Thalia Therapeutics Plc THAT:LSE stock context
THAT:LSE is the primary listing for Thalia Therapeutics Plc, a public company with a market capitalization of approximately £16.63 million. Thalia Therapeutics is dedicated to developing innovative therapeutic solutions. The company’s official page provides updates on its operations, recent news, regulatory filings, and upcoming events relevant to investors and stakeholders.
Research Thalia Therapeutics Plc
Thalia Therapeutics Plc investor report
Review AI stock analysis and investor report context for THAT:LSE.
Thalia Therapeutics Plc company profile
View the public company page for Thalia Therapeutics Plc on 6ix.
Thalia Therapeutics Plc news
Read company news and market updates connected to Thalia Therapeutics Plc.
Thalia Therapeutics Plc investor events
Find investor webinars, events, and replay context for Thalia Therapeutics Plc.
Alternate listings
A2DQES:LSX
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
A2DQES:LS
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
0GO:SWB
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
THAT.GB:AQUIS
GB · GBX
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.
0GO:FWB
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is THAT:LSE.